InnovAge
INNV
$6.53
Share price
-3.12%
Change (1 day)
51.86%
Change (1 year)
Categories
InnovAge (INNV) - Cash on Hand
Cash on Hand as of March 2023 : $0.16 B
According to InnovAge's latest financial reports the company has $0.16 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
InnovAge - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-06-30 | $0.18 B | -8.46% |
| 2021-06-30 | $0.20 B | 78.44% |
| 2020-06-30 | $0.11 B | 89.24% |
| 2019-06-30 | $59.66 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Merck MRK | $10.38 B | 6,099.23% | 🇺🇸 USA |
 Cocrystal Pharma
COCP | $32.41 M | -80.65% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $7.41 M | -95.58% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $2.46 B | 1,370.95% | 🇮🇪 Ireland |